Effect of recombinant human activated protein C on apoptosis-related proteins

European Journal of Histochemistry

Volumn 51, Issue 2, 2007, Pages 103-110

  Sakar, Aysin ^a,b   Vatansever, S ^a   Sepit, L ^a   Ozbilgin, K ^a   Yorgancioglu, A ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Department of Histology Embryology ^*  (Turkey)

Author keywords

Apoptosis; Bcl 2; c myc; p21; p53; Recombinant human activated protein C; Sepsis

Indexed keywords

DROTRECOGIN; ENDOTOXIN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MYC PROTEIN, MOUSE; PROTEIN C; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; SEPSIS; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; HUMAN; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ESCHERICHIA COLI;

ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, INBRED C57BL; PROTEIN C; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; SEPSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 38449091062     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Abraham E. Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc 2005; 2: 243-47.
2. Bilbault P, Lavaux T, Lahlou A, Uring-Lambert B, Gaub MP, Ratomponirina C, et al. Transient Bcl-2 gene down-expression in circulating mononuclear cells of severe sepsis patients who died despite appropriate intensive care. Intensive Care Med 2004; 30: 408-15.
3. Borner C.The Bcl-2 protein family sensors and checkpoints for life-or-death desicions. Mol Immunology 2003; 39: 615-47.
4. Bowen ID. Apoptosis or programmed cell death. Cell Biol Int 1993; 17: 365-80.
5. Brueckmann M, Wizenmann J, Hoffmann U, Seeger M, Bewig B. Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure. Thrombosis Research 2003; 109: 259-63.
6. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 2003; 9: 338-42.
7. Cole MD.The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 1986; 20: 361-84.
8. Coopersmith CM, Chang KC, Swanson PE, Tinsley KW, Stromberg PE, Buchman TG, et al. Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med 2002; 30: 195-201.
9. Cory S, Adams JM.The Bcl-2 family: regeneration of the cellular life or death switch. Nat Rev Cancer 2002; 2: 647-56.
10. Cummings MC, Winterford CM, Walker NI. Apoptosis. In: Stenberg SS, ed. Histology for Pathologists. 2nd Ed. Lippincott-Raven Publishers, Philadelphia, 1997, pp. 3-21.
11. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999; 19: 1-11.
12. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Nat Acad Sci USA 1999; 96: 14541-6.
13. Hughes H. Recombinant human activated protein C. Int J Antimicrob Agents 2006; 28: 90-4.
14. Iwata A, Stevenson VM, MinardA, Tasch M, Tupper J, Lagasse E, et al. Over-expression of bcl-2 provides protection in septic mice by a trans effect. J Immunol 2003; 171: 3136-41.
15. Jin Z, Gao F, Flagg T, Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem 2004; 279: 40209-19.
16. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-86.
17. Liacos C, Katsaragakis S, Konstadoulakis MM, Messaris EG, Papanicolaou M, Georgiadis GG, et al. Apoptosis in cells of bronchoalveolar lavage: A cellular reaction in patients who die with sepsis and respiratory failure. Crit Care Med 2001; 29: 2310-7.
18. Maxwell SA, Acosta SA, Tombusch K, Davis GE. Expression of Bax, Bcl-2, Waf-1, and PCNA gene products in an immortalized human endothelial cell line undergoing p53-mediated apoptosis. Apoptosis 1997; 2: 442-54.
19. Nagata S and Golstein P. The Fas death factor. Science 1995;267: 1449-56.
20. Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, et al. Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 2006; 48: 28-54.
21. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 2001; 15: 879-92.
22. Okura T, Gang L, Kamitami T, Wada T, Okura I, Wei CF, et al. Protection against Fas/Apo-1 and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 1996; 157: 4277-81.
23. Oltvai Z, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
24. Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, et al. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Clinical Cancer Research 2003; 9: 4595-605.
25. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan J E, Eberstadt M, et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997; 275: 983-86.
26. Selvakumaran M, Lin H-K, Miyashita T, Wang HG, Krajewski S, Reed JC, et al. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: A paradigm for distinct apoptotic pathways. Oncogene 1994; 9: 1791-98.
27. Rice TW, Bernard GR. Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock. Am J Med Sci 2004; 328: 205-14.
28. Wellmer A, von Mering M, Spreer A, Diem R, Eiffert H, Noeske C, et al. Experimental pneumococcal meningitis: Impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in bcl-2-deficient mice. Infect Immun 2004; 72: 3113-9.
29. Zajac-Kaye M. Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer 2001; 34 Suppl 2: S43-46.